APO Research

APO RESEARCH · REPORT

Ginseng, Poria and Atractylodes Macrocephala Powder

Selected research

Market Outlook & Growth Opportunities

Global Ginseng, Poria and Atractylodes Macrocephala Powder Market Outlook and Growth Opportunities 2026

Market perspective

The global Ginseng, Poria and Atractylodes Macrocephala Powder market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Ginseng, Poria and Atractylodes Macrocephala Powder is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Ginseng, Poria and Atractylodes Macrocephala Powder is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ginseng, Poria and Atractylodes Macrocephala Powder is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Ginseng, Poria and Atractylodes Macrocephala Powder market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Ginseng, Poria and Atractylodes Macrocephala Powder market include Chengdu Jiuzhitang Jinding Pharmaceutical Co., Ltd., Chengde Tianyuan Pharmaceutical Co., Ltd., Chengde Xinaimin Pharmaceutical Co., Ltd., Gannan Tibetan Medicine Pharmaceutical Co., Ltd., Gansu Foren Pharmaceutical Technology Co., Ltd., Gansu Taikang Pharmaceutical Co., Ltd., Gansu Zhongtian Jindan Pharmaceutical Co., Ltd., Guangdong Jiatai Pharmaceutical Co., Ltd. and Guangshengyuan Chinese Medicine Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Ginseng, Poria and Atractylodes Macrocephala Powder market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Ginseng, Poria and Atractylodes Macrocephala Powder and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Ginseng, Poria and Atractylodes Macrocephala Powder sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Ginseng, Poria and Atractylodes Macrocephala Powder market size, projected growth trends, production technologies, key applications, and end-use industries.

Ginseng, Poria and Atractylodes Macrocephala Powder Segment by Company

Chengdu Jiuzhitang Jinding Pharmaceutical Co., Ltd.

Chengde Tianyuan Pharmaceutical Co., Ltd.

Chengde Xinaimin Pharmaceutical Co., Ltd.

Gannan Tibetan Medicine Pharmaceutical Co., Ltd.

Gansu Foren Pharmaceutical Technology Co., Ltd.

Gansu Taikang Pharmaceutical Co., Ltd.

Gansu Zhongtian Jindan Pharmaceutical Co., Ltd.

Guangdong Jiatai Pharmaceutical Co., Ltd.

Guangshengyuan Chinese Medicine Co., Ltd.

Heilongjiang Longgui Pharmaceutical Co., Ltd.

Jilin Songliao Pharmaceutical Co., Ltd.

Jilin Tiantai Pharmaceutical Co., Ltd.

Lanzhou Foci Pharmaceutical Co., Ltd.

Langzhi Group Shuangren Pharmaceutical Co., Ltd.

Liaoning Chaohua Pharmaceutical Co., Ltd.

Liaoning Hancaotang Chinese Medicine Co., Ltd.

Shaanxi Momede Qixuehe Pharmaceutical Co., Ltd.

Shenyang Hongyao Group Co., Ltd.

Yunnan Baiyao Group Co., Ltd.

Chongqing Tianzhi Pharmaceutical Co., Ltd.

Ginseng, Poria and Atractylodes Macrocephala Powder Segment by Type

6g

12g

Ginseng, Poria and Atractylodes Macrocephala Powder Segment by Application

Hospital

Clinic

Other

Ginseng, Poria and Atractylodes Macrocephala Powder Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Ginseng, Poria and Atractylodes Macrocephala Powder status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Ginseng, Poria and Atractylodes Macrocephala Powder market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Ginseng, Poria and Atractylodes Macrocephala Powder significant trends, drivers, influence factors in global and regions.

6. To analyze Ginseng, Poria and Atractylodes Macrocephala Powder competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ginseng, Poria and Atractylodes Macrocephala Powder market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ginseng, Poria and Atractylodes Macrocephala Powder and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ginseng, Poria and Atractylodes Macrocephala Powder.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Ginseng, Poria and Atractylodes Macrocephala Powder market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Ginseng, Poria and Atractylodes Macrocephala Powder industry.

Chapter 3: Detailed analysis of Ginseng, Poria and Atractylodes Macrocephala Powder manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Ginseng, Poria and Atractylodes Macrocephala Powder in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Ginseng, Poria and Atractylodes Macrocephala Powder in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Ginseng, Poria and Atractylodes Macrocephala Powder Industry Trends Table 2. Ginseng, Poria and Atractylodes Macrocephala Powder Industry Drivers Table 3. Ginseng, Poria and Atractylodes Macrocephala Powder Industry Opportunities and Challenges Table 4. Ginseng, Poria and Atractylodes Macrocephala Powder Industry Restraints Table 5. Global Ginseng, Poria and Atractylodes Macrocephala Powder Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Ginseng, Poria and Atractylodes Macrocephala Powder Revenue Share by Company (2021-2026) Table 7. Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Volume Share by Company (2021-2026) Table 9. Global Ginseng, Poria and Atractylodes Macrocephala Powder Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Ginseng, Poria and Atractylodes Macrocephala Powder Company Ranking, (2024-2026) & (USD Million) Table 11. Global Ginseng, Poria and Atractylodes Macrocephala Powder Key Company Manufacturing Base & Headquarters Table 12. Global Ginseng, Poria and Atractylodes Macrocephala Powder Company, Product Type & Application Table 13. Global Ginseng, Poria and Atractylodes Macrocephala Powder Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Ginseng, Poria and Atractylodes Macrocephala Powder by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 6g Table 18. Significant Companies of 12g Table 19. Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Volume Share by Type (2021-2026) Table 23. Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Volume Share by Type (2027-2032) Table 24. Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Type (2021-2026) Table 28. Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Clinic Table 31. Significant Companies of Other Table 32. Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Volume Share by Application (2021-2026) Table 36. Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Volume Share by Application (2027-2032) Table 37. Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Application (2021-2026) Table 41. Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Application (2027-2032) Table 42. Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales by Region (2021-2026) & (K Units) Table 44. Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Market Share by Region (2021-2026) Table 45. Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales by Region (2027-2032) & (K Units) Table 46. Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Market Share by Region (2027-2032) Table 47. Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Region (2021-2026) Table 50. Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Region (2027-2032) Table 52. Global Ginseng, Poria and Atractylodes Macrocephala Powder Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Ginseng, Poria and Atractylodes Macrocephala Powder Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales by Country (2021-2026) & (K Units) Table 57. Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Market Share by Country (2021-2026) Table 58. Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales by Country (2027-2032) & (K Units) Table 59. Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Market Share by Country (2027-2032) Table 60. Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Market Share by Country (2021-2026) Table 62. Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Market Share by Country (2027-2032) Table 64. Chengdu Jiuzhitang Jinding Pharmaceutical Co., Ltd. Company Information Table 65. Chengdu Jiuzhitang Jinding Pharmaceutical Co., Ltd. Business Overview Table 66. Chengdu Jiuzhitang Jinding Pharmaceutical Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Chengdu Jiuzhitang Jinding Pharmaceutical Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Product Portfolio Table 68. Chengdu Jiuzhitang Jinding Pharmaceutical Co., Ltd. Recent Development Table 69. Chengde Tianyuan Pharmaceutical Co., Ltd. Company Information Table 70. Chengde Tianyuan Pharmaceutical Co., Ltd. Business Overview Table 71. Chengde Tianyuan Pharmaceutical Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Chengde Tianyuan Pharmaceutical Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Product Portfolio Table 73. Chengde Tianyuan Pharmaceutical Co., Ltd. Recent Development Table 74. Chengde Xinaimin Pharmaceutical Co., Ltd. Company Information Table 75. Chengde Xinaimin Pharmaceutical Co., Ltd. Business Overview Table 76. Chengde Xinaimin Pharmaceutical Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Chengde Xinaimin Pharmaceutical Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Product Portfolio Table 78. Chengde Xinaimin Pharmaceutical Co., Ltd. Recent Development Table 79. Gannan Tibetan Medicine Pharmaceutical Co., Ltd. Company Information Table 80. Gannan Tibetan Medicine Pharmaceutical Co., Ltd. Business Overview Table 81. Gannan Tibetan Medicine Pharmaceutical Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Gannan Tibetan Medicine Pharmaceutical Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Product Portfolio Table 83. Gannan Tibetan Medicine Pharmaceutical Co., Ltd. Recent Development Table 84. Gansu Foren Pharmaceutical Technology Co., Ltd. Company Information Table 85. Gansu Foren Pharmaceutical Technology Co., Ltd. Business Overview Table 86. Gansu Foren Pharmaceutical Technology Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Gansu Foren Pharmaceutical Technology Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Product Portfolio Table 88. Gansu Foren Pharmaceutical Technology Co., Ltd. Recent Development Table 89. Gansu Taikang Pharmaceutical Co., Ltd. Company Information Table 90. Gansu Taikang Pharmaceutical Co., Ltd. Business Overview Table 91. Gansu Taikang Pharmaceutical Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Gansu Taikang Pharmaceutical Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Product Portfolio Table 93. Gansu Taikang Pharmaceutical Co., Ltd. Recent Development Table 94. Gansu Zhongtian Jindan Pharmaceutical Co., Ltd. Company Information Table 95. Gansu Zhongtian Jindan Pharmaceutical Co., Ltd. Business Overview Table 96. Gansu Zhongtian Jindan Pharmaceutical Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Gansu Zhongtian Jindan Pharmaceutical Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Product Portfolio Table 98. Gansu Zhongtian Jindan Pharmaceutical Co., Ltd. Recent Development Table 99. Guangdong Jiatai Pharmaceutical Co., Ltd. Company Information Table 100. Guangdong Jiatai Pharmaceutical Co., Ltd. Business Overview Table 101. Guangdong Jiatai Pharmaceutical Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Guangdong Jiatai Pharmaceutical Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Product Portfolio Table 103. Guangdong Jiatai Pharmaceutical Co., Ltd. Recent Development Table 104. Guangshengyuan Chinese Medicine Co., Ltd. Company Information Table 105. Guangshengyuan Chinese Medicine Co., Ltd. Business Overview Table 106. Guangshengyuan Chinese Medicine Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Guangshengyuan Chinese Medicine Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Product Portfolio Table 108. Guangshengyuan Chinese Medicine Co., Ltd. Recent Development Table 109. Heilongjiang Longgui Pharmaceutical Co., Ltd. Company Information Table 110. Heilongjiang Longgui Pharmaceutical Co., Ltd. Business Overview Table 111. Heilongjiang Longgui Pharmaceutical Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Heilongjiang Longgui Pharmaceutical Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Product Portfolio Table 113. Heilongjiang Longgui Pharmaceutical Co., Ltd. Recent Development Table 114. Jilin Songliao Pharmaceutical Co., Ltd. Company Information Table 115. Jilin Songliao Pharmaceutical Co., Ltd. Business Overview Table 116. Jilin Songliao Pharmaceutical Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Jilin Songliao Pharmaceutical Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Product Portfolio Table 118. Jilin Songliao Pharmaceutical Co., Ltd. Recent Development Table 119. Jilin Tiantai Pharmaceutical Co., Ltd. Company Information Table 120. Jilin Tiantai Pharmaceutical Co., Ltd. Business Overview Table 121. Jilin Tiantai Pharmaceutical Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Jilin Tiantai Pharmaceutical Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Product Portfolio Table 123. Jilin Tiantai Pharmaceutical Co., Ltd. Recent Development Table 124. Lanzhou Foci Pharmaceutical Co., Ltd. Company Information Table 125. Lanzhou Foci Pharmaceutical Co., Ltd. Business Overview Table 126. Lanzhou Foci Pharmaceutical Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Lanzhou Foci Pharmaceutical Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Product Portfolio Table 128. Lanzhou Foci Pharmaceutical Co., Ltd. Recent Development Table 129. Langzhi Group Shuangren Pharmaceutical Co., Ltd. Company Information Table 130. Langzhi Group Shuangren Pharmaceutical Co., Ltd. Business Overview Table 131. Langzhi Group Shuangren Pharmaceutical Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Langzhi Group Shuangren Pharmaceutical Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Product Portfolio Table 133. Langzhi Group Shuangren Pharmaceutical Co., Ltd. Recent Development Table 134. Liaoning Chaohua Pharmaceutical Co., Ltd. Company Information Table 135. Liaoning Chaohua Pharmaceutical Co., Ltd. Business Overview Table 136. Liaoning Chaohua Pharmaceutical Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Liaoning Chaohua Pharmaceutical Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Product Portfolio Table 138. Liaoning Chaohua Pharmaceutical Co., Ltd. Recent Development Table 139. Liaoning Hancaotang Chinese Medicine Co., Ltd. Company Information Table 140. Liaoning Hancaotang Chinese Medicine Co., Ltd. Business Overview Table 141. Liaoning Hancaotang Chinese Medicine Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. Liaoning Hancaotang Chinese Medicine Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Product Portfolio Table 143. Liaoning Hancaotang Chinese Medicine Co., Ltd. Recent Development Table 144. Shaanxi Momede Qixuehe Pharmaceutical Co., Ltd. Company Information Table 145. Shaanxi Momede Qixuehe Pharmaceutical Co., Ltd. Business Overview Table 146. Shaanxi Momede Qixuehe Pharmaceutical Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 147. Shaanxi Momede Qixuehe Pharmaceutical Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Product Portfolio Table 148. Shaanxi Momede Qixuehe Pharmaceutical Co., Ltd. Recent Development Table 149. Shenyang Hongyao Group Co., Ltd. Company Information Table 150. Shenyang Hongyao Group Co., Ltd. Business Overview Table 151. Shenyang Hongyao Group Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 152. Shenyang Hongyao Group Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Product Portfolio Table 153. Shenyang Hongyao Group Co., Ltd. Recent Development Table 154. Yunnan Baiyao Group Co., Ltd. Company Information Table 155. Yunnan Baiyao Group Co., Ltd. Business Overview Table 156. Yunnan Baiyao Group Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 157. Yunnan Baiyao Group Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Product Portfolio Table 158. Yunnan Baiyao Group Co., Ltd. Recent Development Table 159. Chongqing Tianzhi Pharmaceutical Co., Ltd. Company Information Table 160. Chongqing Tianzhi Pharmaceutical Co., Ltd. Business Overview Table 161. Chongqing Tianzhi Pharmaceutical Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 162. Chongqing Tianzhi Pharmaceutical Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Product Portfolio Table 163. Chongqing Tianzhi Pharmaceutical Co., Ltd. Recent Development Table 164. Key Raw Materials Table 165. Raw Materials Key Suppliers Table 166. Ginseng, Poria and Atractylodes Macrocephala Powder Distributors List Table 167. Ginseng, Poria and Atractylodes Macrocephala Powder Customers List Table 168. Research Programs/Design for This Report Table 169. Authors List of This Report Table 170. Secondary Sources Table 171. Primary Sources List of Figures Figure 1. Ginseng, Poria and Atractylodes Macrocephala Powder Product Image Figure 2. Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value (2021-2032) & (US$ Million) Figure 4. Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales (2021-2032) & (K Units) Figure 5. Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Ginseng, Poria and Atractylodes Macrocephala Powder Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 6g Image Figure 10. 12g Image Figure 11. Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Volume Share by Type (2021-2032) Figure 14. Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Other Image Figure 20. Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Volume Share by Application (2021-2032) Figure 23. Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Application (2021-2032) Figure 26. Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value (2021-2032) & (US$ Million) Figure 31. North America Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value (2021-2032) & (US$ Million) Figure 37. South America Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Growth Rate (2021-2032) & (

Scope & coverage.

Types
  • 6g
  • 12g
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Chengdu Jiuzhitang Jinding Pharmaceutical Co., Ltd.
  • Chengde Tianyuan Pharmaceutical Co., Ltd.
  • Chengde Xinaimin Pharmaceutical Co., Ltd.
  • Gannan Tibetan Medicine Pharmaceutical Co., Ltd.
  • Gansu Foren Pharmaceutical Technology Co., Ltd.
  • Gansu Taikang Pharmaceutical Co., Ltd.
  • Gansu Zhongtian Jindan Pharmaceutical Co., Ltd.
  • Guangdong Jiatai Pharmaceutical Co., Ltd.
  • Guangshengyuan Chinese Medicine Co., Ltd.
  • Heilongjiang Longgui Pharmaceutical Co., Ltd.
  • Jilin Songliao Pharmaceutical Co., Ltd.
  • Jilin Tiantai Pharmaceutical Co., Ltd.
  • Lanzhou Foci Pharmaceutical Co., Ltd.
  • Langzhi Group Shuangren Pharmaceutical Co., Ltd.
  • Liaoning Chaohua Pharmaceutical Co., Ltd.
  • Liaoning Hancaotang Chinese Medicine Co., Ltd.
  • Shaanxi Momede Qixuehe Pharmaceutical Co., Ltd.
  • Shenyang Hongyao Group Co., Ltd.
  • Yunnan Baiyao Group Co., Ltd.
  • Chongqing Tianzhi Pharmaceutical Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value (2021-2032)
  4. 1.2.2 Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Volume (2021-2032)
  5. 1.2.3 Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Ginseng, Poria and Atractylodes Macrocephala Powder Market Dynamics
  1. 2.1 Ginseng, Poria and Atractylodes Macrocephala Powder Industry Trends
  2. 2.2 Ginseng, Poria and Atractylodes Macrocephala Powder Industry Drivers
  3. 2.3 Ginseng, Poria and Atractylodes Macrocephala Powder Industry Opportunities and Challenges
  4. 2.4 Ginseng, Poria and Atractylodes Macrocephala Powder Industry Restraints
3 Ginseng, Poria and Atractylodes Macrocephala Powder Market by Company
  1. 3.1 Global Ginseng, Poria and Atractylodes Macrocephala Powder Company Revenue Ranking in 2025
  2. 3.2 Global Ginseng, Poria and Atractylodes Macrocephala Powder Revenue by Company (2021-2026)
  3. 3.3 Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Volume by Company (2021-2026)
  4. 3.4 Global Ginseng, Poria and Atractylodes Macrocephala Powder Average Price by Company (2021-2026)
  5. 3.5 Global Ginseng, Poria and Atractylodes Macrocephala Powder Company Ranking (2024-2026)
  6. 3.6 Global Ginseng, Poria and Atractylodes Macrocephala Powder Company Manufacturing Base and Headquarters
  7. 3.7 Global Ginseng, Poria and Atractylodes Macrocephala Powder Company Product Type and Application
  8. 3.8 Global Ginseng, Poria and Atractylodes Macrocephala Powder Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Ginseng, Poria and Atractylodes Macrocephala Powder Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Ginseng, Poria and Atractylodes Macrocephala Powder Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Ginseng, Poria and Atractylodes Macrocephala Powder Market by Type
  1. 4.1 Ginseng, Poria and Atractylodes Macrocephala Powder Type Introduction
  2. 4.1.1 6g
  3. 4.1.2 12g
  4. 4.2 Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Volume by Type
  5. 4.2.1 Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value by Type
  9. 4.3.1 Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value by Type (2021-2032)
  11. 4.3.3 Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Type (2021-2032)
5 Ginseng, Poria and Atractylodes Macrocephala Powder Market by Application
  1. 5.1 Ginseng, Poria and Atractylodes Macrocephala Powder Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Volume by Application
  6. 5.2.1 Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value by Application
  10. 5.3.1 Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value by Application (2021-2032)
  12. 5.3.3 Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Application (2021-2032)
6 Ginseng, Poria and Atractylodes Macrocephala Powder Regional Sales and Value Analysis
  1. 6.1 Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales by Region (2021-2032)
  3. 6.2.1 Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales by Region: 2021-2026
  4. 6.2.2 Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales by Region (2027-2032)
  5. 6.3 Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value by Region (2021-2032)
  7. 6.4.1 Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value by Region: 2021-2026
  8. 6.4.2 Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value by Region (2027-2032)
  9. 6.5 Global Ginseng, Poria and Atractylodes Macrocephala Powder Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value (2021-2032)
  12. 6.6.2 North America Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value (2021-2032)
  15. 6.7.2 Europe Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value (2021-2032)
  21. 6.9.2 South America Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Country, 2025 VS 2032
7 Ginseng, Poria and Atractylodes Macrocephala Powder Country-level Sales and Value Analysis
  1. 7.1 Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales by Country (2021-2032)
  4. 7.3.1 Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales by Country (2021-2026)
  5. 7.3.2 Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales by Country (2027-2032)
  6. 7.4 Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value by Country (2021-2032)
  7. 7.4.1 Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value by Country (2021-2026)
  8. 7.4.2 Global Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Ginseng, Poria and Atractylodes Macrocephala Powder Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Chengdu Jiuzhitang Jinding Pharmaceutical Co., Ltd.
  2. 8.1.1 Chengdu Jiuzhitang Jinding Pharmaceutical Co., Ltd. Company Information
  3. 8.1.2 Chengdu Jiuzhitang Jinding Pharmaceutical Co., Ltd. Business Overview
  4. 8.1.3 Chengdu Jiuzhitang Jinding Pharmaceutical Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Chengdu Jiuzhitang Jinding Pharmaceutical Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Product Portfolio
  6. 8.1.5 Chengdu Jiuzhitang Jinding Pharmaceutical Co., Ltd. Recent Developments
  7. 8.2 Chengde Tianyuan Pharmaceutical Co., Ltd.
  8. 8.2.1 Chengde Tianyuan Pharmaceutical Co., Ltd. Company Information
  9. 8.2.2 Chengde Tianyuan Pharmaceutical Co., Ltd. Business Overview
  10. 8.2.3 Chengde Tianyuan Pharmaceutical Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Chengde Tianyuan Pharmaceutical Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Product Portfolio
  12. 8.2.5 Chengde Tianyuan Pharmaceutical Co., Ltd. Recent Developments
  13. 8.3 Chengde Xinaimin Pharmaceutical Co., Ltd.
  14. 8.3.1 Chengde Xinaimin Pharmaceutical Co., Ltd. Company Information
  15. 8.3.2 Chengde Xinaimin Pharmaceutical Co., Ltd. Business Overview
  16. 8.3.3 Chengde Xinaimin Pharmaceutical Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Chengde Xinaimin Pharmaceutical Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Product Portfolio
  18. 8.3.5 Chengde Xinaimin Pharmaceutical Co., Ltd. Recent Developments
  19. 8.4 Gannan Tibetan Medicine Pharmaceutical Co., Ltd.
  20. 8.4.1 Gannan Tibetan Medicine Pharmaceutical Co., Ltd. Company Information
  21. 8.4.2 Gannan Tibetan Medicine Pharmaceutical Co., Ltd. Business Overview
  22. 8.4.3 Gannan Tibetan Medicine Pharmaceutical Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Gannan Tibetan Medicine Pharmaceutical Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Product Portfolio
  24. 8.4.5 Gannan Tibetan Medicine Pharmaceutical Co., Ltd. Recent Developments
  25. 8.5 Gansu Foren Pharmaceutical Technology Co., Ltd.
  26. 8.5.1 Gansu Foren Pharmaceutical Technology Co., Ltd. Company Information
  27. 8.5.2 Gansu Foren Pharmaceutical Technology Co., Ltd. Business Overview
  28. 8.5.3 Gansu Foren Pharmaceutical Technology Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Gansu Foren Pharmaceutical Technology Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Product Portfolio
  30. 8.5.5 Gansu Foren Pharmaceutical Technology Co., Ltd. Recent Developments
  31. 8.6 Gansu Taikang Pharmaceutical Co., Ltd.
  32. 8.6.1 Gansu Taikang Pharmaceutical Co., Ltd. Company Information
  33. 8.6.2 Gansu Taikang Pharmaceutical Co., Ltd. Business Overview
  34. 8.6.3 Gansu Taikang Pharmaceutical Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Gansu Taikang Pharmaceutical Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Product Portfolio
  36. 8.6.5 Gansu Taikang Pharmaceutical Co., Ltd. Recent Developments
  37. 8.7 Gansu Zhongtian Jindan Pharmaceutical Co., Ltd.
  38. 8.7.1 Gansu Zhongtian Jindan Pharmaceutical Co., Ltd. Company Information
  39. 8.7.2 Gansu Zhongtian Jindan Pharmaceutical Co., Ltd. Business Overview
  40. 8.7.3 Gansu Zhongtian Jindan Pharmaceutical Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Gansu Zhongtian Jindan Pharmaceutical Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Product Portfolio
  42. 8.7.5 Gansu Zhongtian Jindan Pharmaceutical Co., Ltd. Recent Developments
  43. 8.8 Guangdong Jiatai Pharmaceutical Co., Ltd.
  44. 8.8.1 Guangdong Jiatai Pharmaceutical Co., Ltd. Company Information
  45. 8.8.2 Guangdong Jiatai Pharmaceutical Co., Ltd. Business Overview
  46. 8.8.3 Guangdong Jiatai Pharmaceutical Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Guangdong Jiatai Pharmaceutical Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Product Portfolio
  48. 8.8.5 Guangdong Jiatai Pharmaceutical Co., Ltd. Recent Developments
  49. 8.9 Guangshengyuan Chinese Medicine Co., Ltd.
  50. 8.9.1 Guangshengyuan Chinese Medicine Co., Ltd. Company Information
  51. 8.9.2 Guangshengyuan Chinese Medicine Co., Ltd. Business Overview
  52. 8.9.3 Guangshengyuan Chinese Medicine Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Guangshengyuan Chinese Medicine Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Product Portfolio
  54. 8.9.5 Guangshengyuan Chinese Medicine Co., Ltd. Recent Developments
  55. 8.10 Heilongjiang Longgui Pharmaceutical Co., Ltd.
  56. 8.10.1 Heilongjiang Longgui Pharmaceutical Co., Ltd. Company Information
  57. 8.10.2 Heilongjiang Longgui Pharmaceutical Co., Ltd. Business Overview
  58. 8.10.3 Heilongjiang Longgui Pharmaceutical Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Heilongjiang Longgui Pharmaceutical Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Product Portfolio
  60. 8.10.5 Heilongjiang Longgui Pharmaceutical Co., Ltd. Recent Developments
  61. 8.11 Jilin Songliao Pharmaceutical Co., Ltd.
  62. 8.11.1 Jilin Songliao Pharmaceutical Co., Ltd. Company Information
  63. 8.11.2 Jilin Songliao Pharmaceutical Co., Ltd. Business Overview
  64. 8.11.3 Jilin Songliao Pharmaceutical Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Jilin Songliao Pharmaceutical Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Product Portfolio
  66. 8.11.5 Jilin Songliao Pharmaceutical Co., Ltd. Recent Developments
  67. 8.12 Jilin Tiantai Pharmaceutical Co., Ltd.
  68. 8.12.1 Jilin Tiantai Pharmaceutical Co., Ltd. Company Information
  69. 8.12.2 Jilin Tiantai Pharmaceutical Co., Ltd. Business Overview
  70. 8.12.3 Jilin Tiantai Pharmaceutical Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Jilin Tiantai Pharmaceutical Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Product Portfolio
  72. 8.12.5 Jilin Tiantai Pharmaceutical Co., Ltd. Recent Developments
  73. 8.13 Lanzhou Foci Pharmaceutical Co., Ltd.
  74. 8.13.1 Lanzhou Foci Pharmaceutical Co., Ltd. Company Information
  75. 8.13.2 Lanzhou Foci Pharmaceutical Co., Ltd. Business Overview
  76. 8.13.3 Lanzhou Foci Pharmaceutical Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Lanzhou Foci Pharmaceutical Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Product Portfolio
  78. 8.13.5 Lanzhou Foci Pharmaceutical Co., Ltd. Recent Developments
  79. 8.14 Langzhi Group Shuangren Pharmaceutical Co., Ltd.
  80. 8.14.1 Langzhi Group Shuangren Pharmaceutical Co., Ltd. Company Information
  81. 8.14.2 Langzhi Group Shuangren Pharmaceutical Co., Ltd. Business Overview
  82. 8.14.3 Langzhi Group Shuangren Pharmaceutical Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Langzhi Group Shuangren Pharmaceutical Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Product Portfolio
  84. 8.14.5 Langzhi Group Shuangren Pharmaceutical Co., Ltd. Recent Developments
  85. 8.15 Liaoning Chaohua Pharmaceutical Co., Ltd.
  86. 8.15.1 Liaoning Chaohua Pharmaceutical Co., Ltd. Company Information
  87. 8.15.2 Liaoning Chaohua Pharmaceutical Co., Ltd. Business Overview
  88. 8.15.3 Liaoning Chaohua Pharmaceutical Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Liaoning Chaohua Pharmaceutical Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Product Portfolio
  90. 8.15.5 Liaoning Chaohua Pharmaceutical Co., Ltd. Recent Developments
  91. 8.16 Liaoning Hancaotang Chinese Medicine Co., Ltd.
  92. 8.16.1 Liaoning Hancaotang Chinese Medicine Co., Ltd. Company Information
  93. 8.16.2 Liaoning Hancaotang Chinese Medicine Co., Ltd. Business Overview
  94. 8.16.3 Liaoning Hancaotang Chinese Medicine Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Liaoning Hancaotang Chinese Medicine Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Product Portfolio
  96. 8.16.5 Liaoning Hancaotang Chinese Medicine Co., Ltd. Recent Developments
  97. 8.17 Shaanxi Momede Qixuehe Pharmaceutical Co., Ltd.
  98. 8.17.1 Shaanxi Momede Qixuehe Pharmaceutical Co., Ltd. Company Information
  99. 8.17.2 Shaanxi Momede Qixuehe Pharmaceutical Co., Ltd. Business Overview
  100. 8.17.3 Shaanxi Momede Qixuehe Pharmaceutical Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Shaanxi Momede Qixuehe Pharmaceutical Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Product Portfolio
  102. 8.17.5 Shaanxi Momede Qixuehe Pharmaceutical Co., Ltd. Recent Developments
  103. 8.18 Shenyang Hongyao Group Co., Ltd.
  104. 8.18.1 Shenyang Hongyao Group Co., Ltd. Company Information
  105. 8.18.2 Shenyang Hongyao Group Co., Ltd. Business Overview
  106. 8.18.3 Shenyang Hongyao Group Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Shenyang Hongyao Group Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Product Portfolio
  108. 8.18.5 Shenyang Hongyao Group Co., Ltd. Recent Developments
  109. 8.19 Yunnan Baiyao Group Co., Ltd.
  110. 8.19.1 Yunnan Baiyao Group Co., Ltd. Company Information
  111. 8.19.2 Yunnan Baiyao Group Co., Ltd. Business Overview
  112. 8.19.3 Yunnan Baiyao Group Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Yunnan Baiyao Group Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Product Portfolio
  114. 8.19.5 Yunnan Baiyao Group Co., Ltd. Recent Developments
  115. 8.20 Chongqing Tianzhi Pharmaceutical Co., Ltd.
  116. 8.20.1 Chongqing Tianzhi Pharmaceutical Co., Ltd. Company Information
  117. 8.20.2 Chongqing Tianzhi Pharmaceutical Co., Ltd. Business Overview
  118. 8.20.3 Chongqing Tianzhi Pharmaceutical Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 Chongqing Tianzhi Pharmaceutical Co., Ltd. Ginseng, Poria and Atractylodes Macrocephala Powder Product Portfolio
  120. 8.20.5 Chongqing Tianzhi Pharmaceutical Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Ginseng, Poria and Atractylodes Macrocephala Powder Value Chain Analysis
  2. 9.1.1 Ginseng, Poria and Atractylodes Macrocephala Powder Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Ginseng, Poria and Atractylodes Macrocephala Powder Sales Mode & Process
  6. 9.2 Ginseng, Poria and Atractylodes Macrocephala Powder Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Ginseng, Poria and Atractylodes Macrocephala Powder Distributors
  9. 9.2.3 Ginseng, Poria and Atractylodes Macrocephala Powder Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research